Home
Search
Study Topics
Glossary
|
|
|
|
|
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date † | April 19, 2007 | ||||
Last Updated Date | January 20, 2009 | ||||
Start Date † | February 2005 | ||||
Current Primary Outcome Measures † |
Postprandial changes in: total plasma triacylglyceride; Chylomicron triacylglyceride; Cholesterol | ||||
Original Primary Outcome Measures † | Same as current | ||||
Change History | Complete list of historical versions of study NCT00464035 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures † |
Postprandial changes in:insulin; glucose; CCK; Ghrelin; GLP-1, appetite measured by visual analogue scales, BCAA | ||||
Original Secondary Outcome Measures † | Same as current | ||||
Descriptive Information | |||||
Brief Title † | The Effect of Calcium on Postprandial Lipid Profile and Appetite | ||||
Official Title † | |||||
Brief Summary | The purpose of this study is to investigate the effect of calcium on postprandial lipid profile and appetite. |
||||
Detailed Description | Several reports have found inverse associations between calcium intake and body weight. Intervention studies have shown that a high calcium diet resulted in a greater body weight loss than a low calcium diet. In addition, it seems that calcium from dairy products have a more profound effect than calcium from supplements. The mechanism of this additional dairy effect is not yet clear, but one possible explanation could be reduced absorption of fat in the gut. The increase in fecal fat excretion on a high calcium diet could be due to the formation of calcium-fatty acid soaps in the gut. The long term effect of a high calcium intake have been under intense investigation, but as far as we know the acute effect of a high calcium intake have not yet been examined. A study concerning the acute effects could help us understand the effect of calcium on the absorption of fat. After a meal triglyceride (TG) is packaged with cholesterol, lipoproteins and other lipids into particles called chylomicrons. Earlier studies have shown that the fatty acid pattern of chylomicron lipids postprandial was very similar to that of the ingested fat. If we assume that calcium inhibits the absorption of fat, we would expect a reduced total plasma triglyceride concentration after a calcium-rich meal. Appetite involves many different sensations among which hunger and satiety are the most investigated. Several different hormones are involved in the regulation of appetite. Some of these hormones are known to respond to the intake or absorption of fat. If the absorption of fat is inhibited the regulation of appetite most likely will be affected. In the long term this could be important because an increased appetite probably would increase energy intake and thereby reducing the weight loss we otherwise might have accomplished by the reduced absorption of fat. |
||||
Study Phase | |||||
Study Type † | Interventional | ||||
Study Design † | Other, Randomized, Open Label, Placebo Control, Crossover Assignment, Efficacy Study | ||||
Condition † | Obesity | ||||
Intervention † | Behavioral: high calcium intake | ||||
Study Arms / Comparison Groups | |||||
Publications * | |||||
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status † | Completed | ||||
Enrollment † | 18 | ||||
Completion Date | October 2005 | ||||
Primary Completion Date | |||||
Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
||||
Gender | Male | ||||
Ages | 18 Years to 50 Years | ||||
Accepts Healthy Volunteers | Yes | ||||
Contacts †† | |||||
Location Countries † | Denmark | ||||
Expanded Access Status | |||||
Administrative Information | |||||
NCT ID † | NCT00464035 | ||||
Responsible Party | |||||
Secondary IDs †† | |||||
Study Sponsor † | University of Copenhagen | ||||
Collaborators †† |
|
||||
Investigators † |
|
||||
Information Provided By | University of Copenhagen | ||||
Verification Date | December 2004 | ||||
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |